Marcus & Millichap Inc.
09/15/2025 | Press release | Archived content
Marcus & Millichap Arranges Sale of Life Sciences Headquarters and Research Facility in Metro Atlanta
Press Releases
Marcus & Millichap Arranges Sale of Life Sciences Headquarters and Research Facility in Metro Atlanta
September 15, 2025
LinkedIn Email App
MARIETTA, Ga., Sept. 15, 2025 - Marcus & Millichap (NYSE: MMI), a leading commercial real estate brokerage firm specializing in investment sales, financing, research and advisory services, announced today the sale of the two-story, 79,854-square-foot MiMedx corporate headquarters and research facility in Marietta, Georgia. The asset sold for $12.9 million.
"The MiMedx property sale demonstrates the value we provide to our clients. This single-tenant asset was unique and required a targeted and proactive marketing campaign to identify high probability buyers," said David Gant, senior director investments. "This effort generated multiple offers and resulted in a successful closing for our client."
Gant and Lori Schneider, executive managing director investments, represented the seller in association with John Leonard the firm's broker of record in Georgia.
Located at 1775 W. Oak Commons Court in Marietta, the property was built in 1993 and sits on a 7.17-acre site with 291 parking spaces. The building includes laboratory and clean-room space, a warehouse with two roll-up doors and a loading dock and executive office areas with conference rooms. Recent capital improvements include a roof replacement and upgraded HVAC systems. Situated in North Atlanta, the property offers convenient access to Interstate 75.
MiMedx Group Inc. (Nasdaq: MDXG), the tenant, is a biopharmaceutical company specializing in regenerative medicine and placental tissue allografts. Founded in 2008, the company employs nearly 900 people.
"The MiMedx property sale demonstrates the value we provide to our clients. This single-tenant asset was unique and required a targeted and proactive marketing campaign to identify high probability buyers," said David Gant, senior director investments. "This effort generated multiple offers and resulted in a successful closing for our client."
Gant and Lori Schneider, executive managing director investments, represented the seller in association with John Leonard the firm's broker of record in Georgia.
Located at 1775 W. Oak Commons Court in Marietta, the property was built in 1993 and sits on a 7.17-acre site with 291 parking spaces. The building includes laboratory and clean-room space, a warehouse with two roll-up doors and a loading dock and executive office areas with conference rooms. Recent capital improvements include a roof replacement and upgraded HVAC systems. Situated in North Atlanta, the property offers convenient access to Interstate 75.
MiMedx Group Inc. (Nasdaq: MDXG), the tenant, is a biopharmaceutical company specializing in regenerative medicine and placental tissue allografts. Founded in 2008, the company employs nearly 900 people.
# # #
About Marcus & Millichap, Inc. (NYSE: MMI)
Marcus & Millichap, Inc. is a leading brokerage firm specializing in commercial real estate investment sales, financing, research and advisory services with offices throughout the United States and Canada. As of December 31, 2024, the company had 1,712 investment sales and financing professionals in over 80 offices who provide investment brokerage and financing services to sellers and buyers of commercial real estate. The company also offers market research, consulting and advisory services to clients. Marcus & Millichap closed 7,836 transactions in 2024, with a sales volume of approximately $49.6 billion. For additional information, please visit https://www.MarcusMillichap.com.
Marcus & Millichap Inc. published this content on September 15, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on September 18, 2025 at 18:37 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]